Disease-modifying effects of ganglioside GM1 in Huntington's disease models.

EMBO Mol Med · 2017 · PMC5666311 · PMID 28993428

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

R6/2 mice receiving GM1 also showed a trend towards increased lifespan, although these results were not statistically significant ( P = 0.10; Fig 1 I).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.